FDA Prioritizes Keytruda Chemotherapy Mesothelioma Combo
In a significant development for mesothelioma patients, the U.S. Food and Drug Administration has accepted priority review for a new supplemental Biologics License Application. The anticipated FDA approval could mark the beginning of a new era in the …